News
MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.
Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.
The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.
Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.
BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...
The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.
Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.
The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.
Fasikl has received 510(k) clearance from the FDA for its Felix NeuroAI Wristband, designed to address tremor-related functional ...
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results